financetom
Business
financetom
/
Business
/
Chemours Prices $600 Million Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chemours Prices $600 Million Notes Offering
Nov 13, 2024 3:14 PM

05:58 PM EST, 11/13/2024 (MT Newswires) -- Chemours ( CC ) said late Wednesday it has priced its private offering of $600 million of 8% senior notes due 2033.

The offering is set to close on Nov. 27, the company said.

Price: 19.77, Change: -0.19, Percent Change: -0.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hut 8, Eric Trump to launch bitcoin mining company
Hut 8, Eric Trump to launch bitcoin mining company
Mar 31, 2025
(Reuters) - Hut 8 ( HUT ) said on Monday it had joined hands with President Donald Trump's son, Eric Trump, to launch a bitcoin mining company called American Bitcoin. Miami, Florida-based Hut 8 ( HUT ) merged the majority of its mining operations for an 80% stake in American Data Centers, a company formed by a group of investors...
Yum! Brands CEO David Gibbs to Retire in Early 2026
Yum! Brands CEO David Gibbs to Retire in Early 2026
Mar 31, 2025
07:33 AM EDT, 03/31/2025 (MT Newswires) -- Yum! Brands ( YUM ) said Monday its chief executive, David Gibbs, plans to retire in Q1 of 2026. Gibbs has been Yum! Brands' ( YUM ) CEO since January 2020, and with the company for 36 years, the company said. The board has formed a committee to oversee the leadership transition, with...
BeiGene Says EMA Panel Recommends Approval of Tevimbra for Lung Cancer
BeiGene Says EMA Panel Recommends Approval of Tevimbra for Lung Cancer
Mar 31, 2025
07:32 AM EDT, 03/31/2025 (MT Newswires) -- BeiGene ( ONC ) said Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Tevimbra combined with etoposide and platinum chemotherapy as a first-line treatment for extensive-stage small cell lung cancer. The company said the recommendation is based on a phase 3 study that showed a...
L3Harris Technologies Closes Sale of CAS Business for $800 Million
L3Harris Technologies Closes Sale of CAS Business for $800 Million
Mar 31, 2025
07:36 AM EDT, 03/31/2025 (MT Newswires) -- L3Harris Technologies ( LHX ) said Monday it has closed the sale of its Commercial Aviation Solutions business to an affiliate of private equity firm TJC for $800 million in cash. L3Harris ( LHX ) received the entire purchase price upon closing of the transaction. The transaction was announced in November 2023. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved